Montana's Adult-Use Cannabis Market Hits $1 Billion Milestone

Montana's cannabis retailers have collectively sold more than $1 billion in adult-use products since the market opened in January 2022, according to new data reported by the Montana Free Press.

The milestone comes as the state's retail licensees set a new annual sales record in 2024, generating $327 million in total cannabis revenue. Adult-use purchases accounted for 90% of that figure, while medical cannabis sales have dropped to just 10% of the market—a dramatic shift from the state's medical-only era.

The billion-dollar threshold represents significant growth for a state that only launched recreational sales three years ago. Montana voters approved adult-use legalization through Initiative 190 in November 2020, but regulatory delays pushed the market launch to early 2022.

Market Maturation

The 90-10 split between adult-use and medical sales mirrors trends seen in other states as recreational markets mature. Colorado, Washington, and Oregon all experienced similar declines in their medical programs once adult-use sales began, as patients found recreational dispensaries more convenient and often better stocked.

Montana's market has grown steadily year-over-year since launch. The $327 million in 2024 sales represents the state's strongest year yet, suggesting the market hasn't reached saturation despite Montana's relatively small population of roughly 1.1 million residents.

That translates to approximately $297 in per-capita cannabis spending for 2024—a figure that puts Montana in the upper tier of state markets when adjusted for population size.

Revenue Implications

The sales figures carry significant implications for state tax revenue. Montana imposes a 20% tax on adult-use cannabis sales, which would generate roughly $58.8 million in tax revenue from 2024's adult-use sales alone.

Those funds are distributed according to the original ballot measure: 10.5% goes to the state general fund, with the remainder split between conservation programs, substance abuse treatment, veterans' services, localities that host dispensaries, and the Department of Revenue for regulatory costs.

The medical program, while shrinking as a percentage of total sales, still generated an estimated $32.7 million in 2024. Medical cannabis faces no sales tax in Montana, though providers pay licensing and other regulatory fees.

What's Next

Montana's cannabis industry continues to face regulatory challenges despite the strong sales numbers. The state legislature has considered various bills to modify the tax structure and licensing requirements, though none have significantly altered the market framework established by I-190.

Industry observers expect continued growth in 2025, particularly as more retail locations open in underserved areas. The state currently has approximately 350 active dispensary licenses, but some counties remain without any retail presence due to local opt-out provisions.

The billion-dollar milestone positions Montana as a mid-sized but growing cannabis market in the national landscape—smaller than major markets like California or Colorado, but outperforming expectations for a state of its size.

This article is based on original reporting by ganjapreneur.com.